Elbit Systems Ltd.
Elbit Systems Ltd. Q3 FY2026 earnings call
November 17, 2026 · fiscal period ended 2026-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-11-17
Management highlights
• Demand and backlog: Backlog reached a record $33 billion at September 30, up $7.8 billion year over year and $1 billion sequentially. The quarterly increase came mainly from Europe; about 74% of backlog was generated in Israel. Approximately 35% is scheduled for delivery through 2027, with the balance in 2028 and later.
• Cash and profitability: Q3 free cash flow was $276 million, versus $101 million a year earlier, with cash conversion above 150%. Nine-month operating cash flow was $862.5 million, versus $461 million. Management cited operating leverage, translating R&D programs into production, and favorable order selection as contributors to margin expansion.
• Manufacturing investment: Production capacity is being expanded at a new southern Israel facility while existing sites continue operating. Automation, robotics, and AI-enabled processes are being introduced to improve yields and throughput. Management said it increased investment versus original plans and remains on track with expansion.
• Technology and programs: High-power laser development continues, with the Sting helicopter-mounted prototype targeted to reach readiness before the Excalibur port-based system. FUSE showcased AI-enabled, one-to-many autonomous combat capabilities, centered on the DominionX operating system. SkyStriker was demonstrated in Germany, including an 80-kilometer handover and autonomous target engagement.
• Awards and portfolio expansion: New awards included ISR and targeting payloads; two European PULS contracts worth approximately $235 million and $260 million; an approximately $200 million Asia-Pacific contract; and a 15-year Israeli artillery training-center contract. The acquisition of Canada’s International Submarine Engineering expands autonomous underwater, mine-countermeasure, and anti-submarine capabilities. Elbit also presented a modular, multi-layer naval protection system.
• Other financial items: The company recognized about $20 million under an Israeli R&D incentive law. Financial expenses fell to $16.3 million from $34.5 million, mainly due to stronger free cash flow and lower average debt. The effective tax rate rose to 11.6% from 8.2%, mainly due to OECD Pillar Two rules. A $9.9 million net other operating income item mainly reflected a gain on a U.S. subsidiary sale. A $1-per-share dividend was declared, payable January 4, 2027.
Segment performance
Revenue was $2.252 billion, up 17.2% year over year from $1.922 billion. Geographic contribution: Israel 38%, Europe 24%, North America 20%, and Asia Pacific 14% (the transcript does not specify the remainder). Segment revenue amounts and segment revenue shares were not disclosed; year-over-year segment growth was: C4I and Cyber +11%, driven mainly by European command-and-control sales; ISTAR and EW +32%, from airborne and land high-power laser, electronic warfare, maritime systems in Asia Pacific, and EW/electro-optical systems in Israel; Land and Armaments +28%, primarily Israeli ammunition and munitions; 26 Defense (formerly Elbit Systems of America) +10%, from U.S. Customs and Border Protection and Project MIPS; Aerospace +4%, reflecting higher Israeli UAV sales, partly offset by lower precision-guided munitions sales in Asia Pacific.
GAAP gross margin was 25.3%, versus 24.9% a year earlier; non-GAAP gross margin was 25.7%, versus 25.2%. GAAP operating income was $233 million (10.3% margin), versus $171 million (8.9%); non-GAAP operating income was $244 million (10.8%), versus $187 million (9.7%). GAAP diluted EPS was $3.70, up 32%; non-GAAP diluted EPS was $4.36, up 30%.
Guidance
• Management expects heightened revenue growth and continued margin expansion in 2027 compared with full-year 2026; the Q&A referred to a high-teens growth outlook. • Management expects growth across segments, particularly Land, ISTAR, and C4I, with PULS/EuroPULS, high-power laser production, and radio systems identified as drivers. 26 Defense growth is expected to include maritime programs, while autonomous maritime capabilities are being broadened through the Canadian acquisition. • Management expects continued margin expansion, citing operating leverage, R&D programs moving into production, and a backlog and opportunity pipeline that permits greater selectivity toward more profitable orders. • Aerospace is expected to be comparatively less dynamic in its avionics/platform business, which depends on OEM and U.S. military production rates; UAV and drone demand is growing more strongly. • Capital expenditure has increased about 30% over the last 12 months, from roughly $220 million to $300 million. Customer-financed facilities are increasingly helping fund capacity expansion and reduce the company’s own capex burden.
Risks
• Management said it sees no major supply-chain or internal-capacity constraints and does not anticipate difficulty meeting commitments, but rapid backlog conversion depends on successfully scaling production and completing facility expansion. • A significant share of backlog is scheduled for 2028 and beyond, so conversion timing and execution remain important; sequential revenue was flat in most regions in Q3, although Latin America doubled from Q2. • Aerospace platform-related sales depend on OEM and U.S. military production levels, which are not growing at the same pace as other businesses. Precision-guided munition sales in Asia Pacific also weighed on Aerospace growth. • Higher tax expense and the OECD Pillar Two minimum-tax rules affected the effective tax rate. The call also included a safe-harbor reminder that forward-looking statements are subject to actual results differing materially.
Q&A highlights
Q: Could supply-chain or internal throughput constraints limit sales growth or backlog conversion? / A: Management said other regions were broadly flat sequentially while Latin America doubled, but emphasized year-over-year growth as its performance measure. It reported no major supply-chain or capacity issues and said expanded production capacity supports delivery commitments.
Q: What are the main expected growth drivers in 2027? / A: Management expects continued growth in Land and ISTAR, alongside strong C4I performance. It highlighted PULS/EuroPULS, Iron Fist, high-power laser, and radio systems, with additional maritime growth in 26 Defense and ISTAR.
Q: How will capacity expansion be funded, and can capex be accelerated? / A: Capex rose about 30% over the last 12 months, from roughly $220 million to $300 million. Customer-funded facilities are becoming more common; arrangements vary and may involve royalties or contracted volumes, helping reduce Elbit’s own capex burden.
Q: What is driving operating-margin expansion, and can it continue? / A: Management cited operating leverage, R&D programs such as high-power laser moving into profitable production, and a backlog that enables selection of higher-margin orders. It described this as the fifth consecutive year of margin expansion.
Q: Why is Aerospace growth comparatively subdued? / A: Avionics demand depends on OEM and U.S. military platform production, which is not rising rapidly. UAV and drone demand is stronger, partly offsetting the slower platform-related business.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $3.70 | $3.67 | +0.8% | $3.35 |
| Revenue | $2.25B | $2.25B | -0.0% | $1.95B |
Transcript
November 17, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.